Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

被引：0
|
作者：
Yunsik Choi
Sanghyuk Lee
Kapyoul Kim
Soo-Hyun Kim
Yeun-Jun Chung
Charles Lee
机构：
[1] Ewha Womans University,Department of Life Sciences
[2] The Catholic University of Korea,Department of Microbiology, Precision Medicine Research Center, IRCGP, College of Medicine
[3] The Jackson Laboratory for Genomic Medicine,undefined
来源：
Experimental & Molecular Medicine | 2018年 / 50卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cancer immunotherapy is a promising way to eliminate tumor cells by using the patient’s own immune system. Selecting the appropriate animal models to develop or validate preclinical immunotherapeutic trials is now an important aspect of many cancer research programs. Here we discuss the advantages and limitations of using genetically engineered immunodeficient mouse models, patient-derived xenografts (PDXs), and humanized mouse models for developing and testing immunotherapeutic strategies.
引用
收藏
页码：1 / 9
页数：8
相关论文
共 50 条
  • [1] Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice
    Choi, Yunsik
    Lee, Sanghyuk
    Kim, Kapyoul
    Kim, Soo-Hyun
    Chung, Yeun-Jun
    Lee, Charles
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2018, 50 : 1 - 9
  • [2] Patient-derived xenografts (PDXs) as model systems for human cancer
    Invrea, Federica
    Rovito, Roberta
    Torchiaro, Erica
    Petti, Consalvo
    Isella, Claudio
    Medico, Enzo
    CURRENT OPINION IN BIOTECHNOLOGY, 2020, 63 : 151 - 156
  • [3] Development of humanized mouse with patient-derived xenografts for cancer immunotherapy studies: A comprehensive review
    Jin, Ke-Tao
    Du, Wen-Lin
    Lan, Huan-Rong
    Liu, Yu-Yao
    Mao, Chun-Sen
    Du, Jin-Lin
    Mou, Xiao-Zhou
    CANCER SCIENCE, 2021, 112 (07) : 2592 - 2606
  • [4] Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics
    Paul Guilhamon
    Lee M Butcher
    Nadege Presneau
    Gareth A Wilson
    Andrew Feber
    Dirk S Paul
    Moritz Schütte
    Johannes Haybaeck
    Ulrich Keilholz
    Jens Hoffman
    Mark T Ross
    Adrienne M Flanagan
    Stephan Beck
    Genome Medicine, 6
  • [5] Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics
    Guilhamon, Paul
    Butcher, Lee M.
    Presneau, Nadege
    Wilson, Gareth A.
    Feber, Andrew
    Paul, Dirk S.
    Scuette, Moritz
    Haybaeck, Johannes
    Keilholz, Ulrich
    Hoffman, Jens
    Ross, Mark T.
    Flanagan, Adrienne M.
    Beck, Stephan
    GENOME MEDICINE, 2014, 6
  • [6] Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma
    Yan, Chi
    Nebhan, Caroline A.
    Saleh, Nabil
    Shattuck-Brandt, Rebecca
    Chen, Sheau-Chiann
    Ayers, Gregory D.
    Weiss, Vivian
    Richmond, Ann
    Vilgelm, Anna E.
    CANCERS, 2023, 15 (14)
  • [7] Patient-derived xenografts in humanized mice classify metastatic potential of primary triple negative breast cancer
    Yu, Chun I.
    Wu, Te-Chia
    Kim, Kyung In
    Menghi, Francesca
    Oliveira, Vanessa
    Marches, Florentina
    Liu, Edison T.
    Banchereau, Jacques
    Palucka, Karolina
    CANCER RESEARCH, 2020, 80 (04)
  • [8] Patient-derived tumor xenografts in humanized NSG mice: a model to study immune responses in cancer therapy
    Wang, Minan
    Keck, James G.
    Cheng, Mingshan
    Cal, Danying
    Shultz, Leonard
    Palucka, Karolina
    Banchereau, Jacques
    Bult, Carol
    Huntress, Rick
    CANCER RESEARCH, 2015, 75
  • [9] Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
    Kleinmanns, Katrin
    Gullaksen, Stein-Erik
    Bredholt, Geir
    Davidson, Ben
    Torkildsen, Cecilie Fredvik
    Grindheim, Sindre
    Bjorge, Line
    McCormack, Emmet
    CANCERS, 2022, 14 (13)
  • [10] A functional mutational profile of a compendium of 350 patient-derived tumor xenografts (PDXs).
    Krumbach, Rebekka
    Virajah, Jagatheswari
    Metcalfe, Thomas
    Fiebig, Heiner
    Vuaroqueaux, Vincent
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
12345